One of the most widely used diabetes drugs, metamorphin, may help fight ovarian cancer.
The researchers at Mayo Clinic followed 61 women with diabetes taking metformin (who also had ovarian cancer) and 178 ovarian cancer patients without diabetes who were not taking the drug. They found out that diabetic patients with ovarian cancer who took metformin had a better survival rate than patients who did not take it. To learn about drug’s impact on survival, metformin-takers and non-takers were matched for age and ovarian cancer stage.
[Read: Treatment of Ovarian Cancer]
Metformin drug (also known as Glucophage) which originates from French Lilac plant is better known to have diuretic properties. It was approved to control blood sugar in the U.S. since the mid-1990s, and it has been used in Europe for more than 50 years. The drug may hold promise for ovarian cancer too.
Read more Health News
-1751527287915.png)
-1751352905978.jpg)
